Literature DB >> 11831361

Type V collagen distribution in liver is reconstructed in coculture system of hepatocytes and stellate cells; the possible functions of type V collagen in liver under normal and pathological conditions.

K K Takai1, S Hattori, S Irie.   

Abstract

The contents of type I, type III and type V collagen and the collagen type specific distributions in liver under normal and cirrhotic conditions were examined. In CCl4 injected rat, the increasing amount of type V collagen was a specific event during the progression of cirrhosis. In normal liver, immunohistochemical observation showed that type V collagen was localized on the fine fibrils, while type I was localized on the thick fibril. Type V collagen was partially colocalized with type IV collagen. In the cirrhotic liver, type V collagen was localized on the margin of the thick fibrous septa along with type IV collagen. Type I collagen existed in the core region of fibrous septa where the stellate cells were prominent. To elucidate the mechanism of the type specific deposition of collagen in the liver, we constructed a coculture system using both stellate cells and hepatocytes. In this system, type V collagen was mainly deposited on hepatocyte colonies not on stellate cells, while type I collagen fibrils were localized on stellate cells. The spatial positioning of type I and type V collagens in vitro was similar to that in the liver. In the cell adhesion assay, the adhesion of stellate cells to type V collagen was poorer than that of the hepatocytes. The collagen type-specific affinity of the stellate cells and hepatocytes may explain the specific localization of type V collagen in the liver and coculture system. These results suggested that the functions of type V collagen are not only to connect type IV collagen with type I collagen fibril, but also to protect the parenchyma from excess type I collagen deposition produced by stellate cells under pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11831361     DOI: 10.1247/csf.26.289

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  5 in total

1.  Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis.

Authors:  Brian B Borg; Anil Seetharam; Vijay Subramanian; Haseeb Ilias Basha; Mauricio Lisker-Melman; Kevin Korenblat; Christopher D Anderson; Surendra Shenoy; William C Chapman; Jeffrey S Crippin; Thalachallour Mohanakumar
Journal:  Liver Transpl       Date:  2011-07       Impact factor: 5.799

2.  Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease.

Authors:  Yukiko Saitou; Katsuya Shiraki; Yutaka Yamanaka; Yumi Yamaguchi; Tomoyuki Kawakita; Norihiko Yamamoto; Kazushi Sugimoto; Kazumoto Murata; Takeshi Nakano
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

3.  Association between decreases in type V collagen and apoptosis in mouse lung chemical carcinogenesis: a preliminary model to study cancer cell behavior.

Authors:  Edwin Roger Parra; Leonardo Cavallari Bielecki; José Mauro da Fonseca Pestana Ribeiro; Fernando de Andrade Balsalobre; Walcy R Teodoro; Vera Luiza Capelozzi
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

Review 4.  Molecular Advances in MAFLD-A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis.

Authors:  Adrian Kołakowski; Sylwia Dziemitko; Aleksandra Chmielecka; Hubert Żywno; Wiktor Bzdęga; Tomasz Charytoniuk; Adrian Chabowski; Karolina Konstantynowicz-Nowicka
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

5.  Circulating levels of a collagen type v propeptide fragment in a carbon tetrachloride reversible model of liver fibrosis.

Authors:  E Vassiliadis; S S Veidal; C Hansen; M A Karsdal; D J Leeming
Journal:  Biomark Insights       Date:  2012-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.